Molecular Mechanisms of Hormone-Mediated Sex Differences in Wound Healing
Project Number1R35GM157032-01
Contact PI/Project LeaderO'BRIEN-COON, DEVIN
Awardee OrganizationBRIGHAM AND WOMEN'S HOSPITAL
Description
Abstract Text
PROJECT ABSTRACT
Wounds have a sizable impact on public health: 1 out of 50 Americans has a chronic wound at any given time
and the cost of wound care exceeds $100 billion per year. Similarly, hypertrophic scars with excessive scar
tissue greatly impair quality of life for millions of patients. However, therapeutic solutions for wound healing
(WH) remain quite limited.
Sex has received growing interest as a factor in wound healing, and some studies show higher rates of non-
healing wounds in men. It has long been known that in male rodents testosterone (T) impairs WH via androgen
receptor effects. Sex hormone (SH)-induced changes in wound repair have been studied as a possible risk
factor, but their impact is uncertain due to factors like illness that alter hormone levels. A novel and promising
way to better understand this link is to examine WH in transgender patients on exogenous hormones.
However, research into the effects of gender-affirming hormones has not kept pace with rapid clinical
population growth. We developed new models and showed that T limits wound healing in large animals with
different effects in XX vs. XY animals. Further, we have shown that patients on T have impaired wound
healing. A critical knowledge gap that remains unaddressed is the set of molecular mechanisms and pathways
testosterone acts through to change the wound healing response. We have identified new immunomodulatory
effects of T that may mediate these effects. Conversely, estradiol (E2) may accelerate wound repair rates.
Essential aspects of how E2 improves wound healing – how E2 levels affect the response, what cell subtypes
E2 acts through, and whether E2 effects differ between XX and XY subjects – remain similarly unknown.
We will address these gaps in understanding sex hormone modulation of WH with a program spanning three
project directions, including overcoming the failure of current in vitro models to recapitulate the in vivo wound
cell behavior changes induced by sex hormones (Project 1: In Vitro System), defining how testosterone
modulates the evolution of the immune response during wound healing to impair closure and how this induces
a fibrotic or regenerative repair response (Project 2: Mechanisms of T Immunomodulation). Finally, we will
expand our work to deeply profile the effects of estradiol on immune cell subtypes and the wound cytokine
milieu and define how sex chromosome complement alters this response (Project 3: Estradiol Wound Healing
Mechanisms). This project will deploy innovative tools to probe SH-WH mechanisms, expanding scientific
knowledge of how T and estradiol interact with sex chromosomes to regulate wound healing biology.
This study seeks to transform current concepts of how hormones modulate wound repair with the dual aim of
improving care for a marginalized patient population and developing potential new approaches for millions of
patients with chronic wounds.
Public Health Relevance Statement
PROJECT NARRATIVE
Wound healing is a major public health problem affecting millions of patients, and preliminary clinical and large
animal data suggest that testosterone may impair wound repair while estrogen improves it, yet the
mechanisms of these effects are poorly understood. In this project we will define the biology of how
testosterone and estradiol act to change the wound immune environment and modulate the process of wound
healing. This work will increase our understanding of biology in an understudied health disparity population and
contribute new, fundamental knowledge of the sex hormone-tissue repair axis.
No Sub Projects information available for 1R35GM157032-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R35GM157032-01
Patents
No Patents information available for 1R35GM157032-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R35GM157032-01
Clinical Studies
No Clinical Studies information available for 1R35GM157032-01
News and More
Related News Releases
No news release information available for 1R35GM157032-01
History
No Historical information available for 1R35GM157032-01
Similar Projects
No Similar Projects information available for 1R35GM157032-01